Short answer
Zimmer Biomet (ZBH) filed an 8-K current report with the SEC on April 28, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). CFO Suketu Upadhyay resigns April 28, 2026, citing a new opportunity and no disagreement with Zimmer Biomet.
Zimmer Biomet 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CFO Suketu Upadhyay resigns April 28, 2026, citing a new opportunity and no disagreement with Zimmer Biomet
- Controller and Chief Accounting Officer Paul Stellato becomes interim CFO while a permanent successor search proceeds
- Stellato’s interim compensation includes $550,000 annualized salary and 70% target bonus, both prorated for 2026 service
- Incremental equity awards total approximately $850,000, including $750,000 RSUs and $100,000 performance-based RSUs
- Leadership transition creates near-term execution risk, though Stellato brings accounting, FP&A, and controllership experience since May 2022
Item EX-99.1 · Exhibit EX-99.1
- CFO Suketu Upadhyay departing April 28, 2026 for a new professional opportunity
- Controller and Chief Accounting Officer Paul Stellato named interim CFO during internal and external search
- Stellato brings more than 20 years of finance and investor-relations experience, supporting near-term leadership continuity
- CFO transition creates execution and succession uncertainty despite management’s stated commitment to strategy and capital allocation
Other items in this filing:
- Item 7.01: Regulation FD Disclosure
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Zimmer Biomet 8-K filings
Get the next ZBH 8-K as it lands
Follow ZBH for push alerts, or ask the research agent what this filing means.